Acadia Pharmaceuticals has appointed Scott Cenci as Senior Vice President, Chief Information and Data Officer. In this role, he will lead the company’s digital transformation, including technology, data, and AI strategy, and serve on Acadia’s Executive Leadership Team. The appointment places Cenci at the center of the company’s effort to build stronger digital, data, and decision-making capabilities across the business.
Cenci brings more than 25 years of experience across the pharmaceutical and biotechnology sectors. Before joining Acadia, he held senior leadership roles at Genmab and Biogen, with prior experience also spanning Zoetis and Pfizer. His background is rooted in enterprise technology, data, cybersecurity, and digital transformation across life sciences organizations.
Why this matters: This appointment signals that Acadia is treating technology, data, and AI as a unified strategic function rather than separate operational tracks. In a pharmaceutical market where digital infrastructure increasingly shapes R&D productivity, commercial execution, and enterprise agility, bringing in a leader with deep life sciences transformation experience suggests Acadia is investing in a more integrated, AI-ready operating model.
